January 3, 2018 / 1:23 PM / in a month

BRIEF-Oncosec Plans To Conduct A Second Clinical Trial In Triple Negative Breast Cancer In 2018​

Jan 3 (Reuters) - Oncosec Medical Inc:

* ONCOSEC PROVIDES 2018 BUSINESS OUTLOOK

* ONCOSEC MEDICAL INC - PLAN TO CONDUCT A SECOND CLINICAL TRIAL IN TRIPLE NEGATIVE BREAST CANCER IN 2018​

* ONCOSEC MEDICAL -‍PLAN TO CONDUCT 2 INVESTIGATOR SPONSORED TRIALS IN SQUAMOUS CELL CARCINOMA OF HEAD, NECK AND IN MELANOMA NEOADJUVANT SETTING IN 2018​

* ONCOSEC MEDICAL INC - PREPARE TO COMMERCIALLY LAUNCH IMMUOPULSE IL-12 IN U.S. IN 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below